The molecular diagnostics company's concurrent CLIA Waiver by Application, if granted, would allow testing in decentralised ...

Over the past four years, many of us have become accustomed to a swab up the nose to test for COVID-19, using at-home rapid antigen tests or the more accurate clinic-provided PCR tests with a longer ...

The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.

Please provide your email address to receive an email when new articles are posted on . University CMV testing among newborns is not common. In Minnesota, the first state with universal CMV testing, a ...

Add Yahoo as a preferred source to see more of our stories on Google. As the federal health emergency ended May 11 and COVID numbers are on the rise, here's how you can still access tests, at-home and ...

Because of its high accuracy, laboratory-based polymerase chain reaction (PCR) testing is the gold standard for infectious disease diagnostics. However, PCR technology requires highly trained staff ...

The healthcare company has introduced two new research-use PCR tests as demand for cyclospora detection grows during an ...

Real-time PCR enables faster Mycoplasma detection to meet rigorous cell therapy safety standards and reduce quality control-related workflow delays. Cell therapy innovation is accelerating, but ...

A new biotechnology company in McKinney has ambitions to become the world's first fully integrated platform for polymerase chain reaction (PCR) testing - the same technology behind a common COVID-19 ...

Roche (RHHBF) launches two new PCR tests to detect the parasite Cyclospora as the U.S. continues to grapple with an outbreak ...